HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Giordani, L. Articles by Iolascon, A. Search for Related Content PubMed PubMed Citation Articles by Giordani, L. Articles by Iolascon, A. Related Collections Molecular Diagnostics and Genetics Evidence Based Laboratory Medicine and Test Utilization Cancer Diagnostics (since 2002)

Association of Breast Cancer and Polymorphisms of Interleukin-10 and Tumor Necrosis Factor- Genes

¹ Department of Biomedicine Evolutive Age, University of Bari, 70124 Bari, Italy

² Department of Clinical Epidemiology, National Cancer Research Institute, 16148 Geneva, Italy

³ Department of Pediatrics, University of Foggia, CEINGE-Advanced Biotechnology, 80131 Naples, Italy
Departments of
⁴ Experimental Oncology and
⁵ Female Cancer, IRCCS-Oncologic Hospital, 70100 Bari, Italy

⁶ Department of Biochemistry and Biophysics, "F. Cedrangolo", II University of Naples, 80138 Naples, Italy

^aaddress correspondence to this author at: Pediatric Department, University of Foggia, CEINGE-Advanced Biotechnology, Via Pansini 5, 80131 Naples, Italy; e-mail iolascon@dbbm.unina.it

The first 300 words of the full text of this article appear below.

We investigated the potential relationship between breast cancer and polymorphisms of the interleukin 10 (IL-10) and tumor necrosis factor- (TNF-) genes.

High plasma TNF- concentrations predict poor cancer outcome (1), weight loss, cachexia, poor immune response, and anemia (2)(3). We studied the -308(G/A) polymorphism because it is the most frequently investigated, it is included in an AP-2 transcription-factor binding site of the TNF- gene (4)(5)(6), and its importance in TNF- gene expression has been demonstrated by reporter gene assays (7). The TNF- -308 polymorphism affects TNF- gene transcription in both a cell-type and stimulus-specific manner, with a remarkable effect in macrophage-like cells (8).

IL-10, an important immunoregulatory cytokine, induces T-cell anergy (9) and prevents tumor antigen presentation to CD8+ cytotoxic T lymphocytes by suppressing expression of MHC class I and II antigens (10). This effect may contribute to the lack of immune response toward transformed cells (11)(12)(13). Three polymorphisms [-1082(G/A), -819(C/T), and -592(C/A)] have been described in the IL-10 promoter region, but data are unclear regarding their influence, alone or in reciprocal linkage, on transcription (14). Higher IL-10 production seems to be associated with -1082 G/G. The positive effect on IL-10 gene expression was substantiated by reporter gene assays (15)(16), although, in some cases, differing results have been described in cells undergoing distinct stimuli (17).

There appears to be conflicting evidence on the interplay between IL-10 and cancer. Indeed, it has been proposed that IL-10 might contribute to tumor escape from the immune response, but it may also exert an antitumor effect. In one study, IL-10-deficient mice developed colitis and colorectal cancer, mirroring the increased . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				W. M. Howell and M. J. Rose-Zerilli Cytokine Gene Polymorphisms, Cancer Susceptibility, and Prognosis J. Nutr., January 1, 2007; 137(1): 194S - 199S. [Abstract] [Full Text] [PDF]